Sanjay Kumar

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 433 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +6

Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis model

Changchun Ren, Sanjay Kumar, Diptiman Chanda et al. · Gene Therapy · 2008 · 202 citations · Full text

Mesenchymal Stem Cells, Medicine, Stem Cells +8

Therapeutic Potential of Mesenchymal Stem Cells Producing Interferon-α in a Mouse Melanoma Lung Metastasis Model

Changchun Ren, Sanjay Kumar, Diptiman Chanda et al. · Stem Cells · 2008 · 192 citations · Full text

Mesenchymal Stem Cells Expressing Osteogenic and Angiogenic Factors Synergistically Enhance Bone Formation in a Mouse Model of Segmental Bone Defect

Sanjay Kumar, Chao Wan, Girish Ramaswamy et al. · Molecular Therapy · 2010 · 159 citations · Full text

Tissue Engineering, Engineering, Mouse Msc +16

Bone homing of mesenchymal stem cells by ectopic α4 integrin expression

Sanjay Kumar, Selvarangan Ponnazhagan · The FASEB Journal · 2007 · 154 citations

Tissue Engineering, Engineering, Bone Repair +21